Success of MDMA in PTSD Study Could Pave the Way for U.S. Approval of the Psychedelic
The psychedelic drug MDMA can reduce symptoms of post-traumatic stress disorder, researchers reported in a new study published Thursday. The company sponsoring the research said it plans later this year to seek U.S. approval to market the drug, also known as ecstasy, as a PTSD treatment when combined with talk therapy. “It’s the first innovation … Read more